Midkine neurite growth-promoting factor 2 expression as a potential prognostic marker of adjuvant therapy in head and neck squamous cell carcinoma

Evaluating the performance of fibronectin 1 (FN1), integrin α4β1 (ITGA4), syndecan-2 (SDC2), and glycoprotein CD44 as the potential biomarkers of oral squamous cell carcinoma (OSCC)

(2012) Ching-Yu Yen et al.   BIOMARKERS

Prognostic value of transforming growth factor beta 1 [TGF-β1] and matrix metalloproteinase 9 [MMP-9] in oral squamous cell carcinoma

(2011) Maryam Elahi et al.   BIOMARKERS

Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population

(2011) Ajay Kumar Chaudhary et al.   BIOMARKERS

Midkine expression in oral squamous cell carcinoma and leukoplakia

(2011) Bruno Correia Jham et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Functional polymorphism of the MMP-1 promoter (-1607 1G/2G) in potentially malignant and malignant head and neck lesions in an Indian population

(2010) Ajay Kumar Chaudhary et al.   BIOMARKERS

Increased drug efflux along with midkine gene high expression in childhood B-lineage acute lymphoblastic leukemia cells

(2010) Ronghua Hu et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Midkine expression in malignant salivary gland tumors and its role in tumor angiogenesis

(2010) Tomoko Ota et al.   ORAL ONCOLOGY

Midkine positively regulates the proliferation of human gastric cancer cells

(2009) Yingying Xu et al.   CANCER LETTERS

Midkine as a prognostic biomarker in oral squamous cell carcinoma

(2008) K Ota et al.   BRITISH JOURNAL OF CANCER

Neck dissection: present and future?

(2008) Alfio Ferlito et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

Identification of a novel therapeutic target for head and neck squamous cell carcinomas: A role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway

(2008) Satoya Shimizu et al.   INTERNATIONAL JOURNAL OF CANCER